Zio AT ECG Monitoring System vs Sleepiz One+

Sleepiz One+ offers contactless monitoring, which is a significant advantage for patient comfort and compliance, especially for long-term monitoring or for patients who may have skin sensitivities or prefer not to wear devices. The device is simply placed on a bedside table or mounted on a wall, requiring minimal patient interaction for setup and daily use. In contrast, the Zio AT requires a patch to be applied to the chest, although it is designed for comfort and can be worn during daily activities including showering.

The Zio AT ECG Monitoring System is specifically designed for comprehensive, long-term arrhythmia detection with continuous ECG recording for up to 14 days, offering a higher diagnostic yield compared to shorter monitoring periods. Its FDA-cleared deep-learned AI algorithm and review by certified cardiographic technicians provide highly accurate and actionable reports for clinicians. Sleepiz One+ provides valuable respiration and heart rate monitoring and sleep apnea screening, but its clinical focus is narrower.

Both tools require contacting the company for specific pricing, indicating a lack of public transparency. However, both mention reimbursement options through CPT codes, suggesting pathways for patients and providers to manage costs. Zio AT's cost can range from $1,000 to $2,500, depending on various factors, and iRhythm offers financial assistance programs. Sleepiz One+ highlights its ability to allow for 16 out of 30 days of measurements for CPT billing purposes, which could be a value proposition for remote patient monitoring. Without detailed pricing structures and typical out-of-pocket costs for various insurance plans, it's difficult to definitively declare a winner in terms of overall pricing and value.

Zio AT has a more established ecosystem for enterprise use, including a dedicated clinician portal (ZioSuite) and mobile app for patient management and report interpretation, as well as EHR integration capabilities. It also has extensive clinical evidence and studies supporting its use in various healthcare settings. While Sleepiz One+ offers a web application for data access and analysis and is being integrated into clinical trial platforms, its enterprise features and widespread adoption in large healthcare systems appear less extensive at this time.

Both tools demonstrate significant innovation in their respective fields. Zio AT leverages FDA-cleared deep-learned AI for highly accurate arrhythmia detection in a wearable patch, offering continuous, long-term ECG monitoring. Sleepiz One+ stands out with its contactless radar technology for remote patient monitoring, providing a novel and less intrusive way to collect vital signs and screen for sleep apnea. The choice of winner depends on which innovative approach is prioritized (wearable AI for cardiac vs. contactless vital signs).

iRhythm provides comprehensive support and documentation for the Zio AT system, including clinical reference manuals, instructions for use, and patient education resources. They also offer a MyZio patient app for symptom logging and education, and a ZioSuite clinician portal. Sleepiz offers quick start guides and an instruction manual for Sleepiz One+, along with FAQs and contact information for support. However, the breadth and depth of publicly available support materials appear more extensive for Zio AT.